PharmAust Files Orphan Medicinal Product Designation for Sclerosis Treatment Following Regulatory Guidance
PharmAust Files Orphan Medicinal Product Designation for Sclerosis Treatment Following Regulatory Guidance
PharmAust根據監管指南爲硬化症治療申請孤兒藥物產品認定。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊